The Somatic Advantage 500 Standard (SA500 Standard) leverages advanced NGS technology to analyze a broad range of mutations across 500+ genes in tumor samples. SA500 Standard covers DNA and RNA analysis, along with Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI).
The SA500 Standard Test is ideal for the genomic profiling of advanced, metastatic cancers, Cancers of Unknown Primary (CUP), and other complex cancers.
Key Features
Covers AMP Tier I/II/III variants in 500+ genes
Utilizes UMI-based library preparation for high sensitivity and accuracy
Covers TMB and MSI
Clinical Applications
Supports eligibility for immune checkpoint inhibitors based on TMB/MSI
Facilitates timely access to clinical trials with comprehensive genomic inclusion criteria
Suitable for tissue-based analysis across all solid tumor types
